ID   PSEB_CAMJJ              Reviewed;         334 AA.
AC   Q5QKR8;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   04-JAN-2005, sequence version 1.
DT   07-JAN-2015, entry version 60.
DE   RecName: Full=UDP-N-acetylglucosamine 4,6-dehydratase (inverting);
DE            EC=4.2.1.115;
DE   AltName: Full=Pseudaminic acid biosynthesis protein B;
DE   AltName: Full=UDP-GlcNAc-inverting 4,6-dehydratase;
GN   Name=pseB; Synonyms=flmA; OrderedLocusNames=CJJ81176_1310;
OS   Campylobacter jejuni subsp. jejuni serotype O:23/36 (strain 81-176).
OC   Bacteria; Proteobacteria; Epsilonproteobacteria; Campylobacterales;
OC   Campylobacteraceae; Campylobacter.
OX   NCBI_TaxID=354242;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=81-176;
RX   PubMed=11461915; DOI=10.1074/jbc.M104529200;
RA   Thibault P., Logan S.M., Kelly J.F., Brisson J.-R., Ewing C.P.,
RA   Trust T.J., Guerry P.;
RT   "Identification of the carbohydrate moieties and glycosylation motifs
RT   in Campylobacter jejuni flagellin.";
RL   J. Biol. Chem. 276:34862-34870(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=81-176;
RX   PubMed=16861657; DOI=10.1128/IAI.00210-06;
RA   Hofreuter D., Tsai J., Watson R.O., Novik V., Altman B., Benitez M.,
RA   Clark C., Perbost C., Jarvie T., Du L., Galan J.E.;
RT   "Unique features of a highly pathogenic Campylobacter jejuni strain.";
RL   Infect. Immun. 74:4694-4707(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=81-176;
RA   Fouts D.E., Nelson K.E., Sebastian Y.;
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PATHWAY, AND DISRUPTION PHENOTYPE.
RC   STRAIN=81-176;
RX   PubMed=14617187; DOI=10.1046/j.1365-2958.2003.03725.x;
RA   Goon S., Kelly J.F., Logan S.M., Ewing C.P., Guerry P.;
RT   "Pseudaminic acid, the major modification on Campylobacter flagellin,
RT   is synthesized via the Cj1293 gene.";
RL   Mol. Microbiol. 50:659-671(2003).
RN   [5]
RP   FUNCTION.
RC   STRAIN=81-176;
RX   PubMed=16684771; DOI=10.1074/jbc.M603777200;
RA   McNally D.J., Hui J.P., Aubry A.J., Mui K.K., Guerry P., Brisson J.R.,
RA   Logan S.M., Soo E.C.;
RT   "Functional characterization of the flagellar glycosylation locus in
RT   Campylobacter jejuni 81-176 using a focused metabolomics approach.";
RL   J. Biol. Chem. 281:18489-18498(2006).
CC   -!- FUNCTION: Catalyzes the first step in the biosynthesis of
CC       pseudaminic acid, a sialic-acid-like sugar that is used to modify
CC       flagellin. Has both C6 dehydratase and C5 epimerase activities
CC       that result in the production of both UDP-2-acetamido-2,6-dideoxy-
CC       beta-L-arabino-4-hexulose and UDP-2-acetamido-2,6-dideoxy-alpha-D-
CC       xylo-4-hexulose. {ECO:0000269|PubMed:16684771}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-glucosamine = UDP-2-
CC       acetamido-2,6-dideoxy-beta-L-arabino-hex-4-ulose + H(2)O.
CC   -!- COFACTOR:
CC       Name=NADP(+); Xref=ChEBI:CHEBI:58349; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Homohexamer. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Cells are non-motile and non-flagellated and
CC       accumulate unglycosylated flagellin intracellularly.
CC       {ECO:0000269|PubMed:14617187}.
CC   -!- SIMILARITY: Belongs to the polysaccharide synthase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY102622; AAP12668.1; -; Genomic_DNA.
DR   EMBL; DQ493920; ABF83716.1; -; Genomic_DNA.
DR   EMBL; CP000538; EAQ72897.1; -; Genomic_DNA.
DR   RefSeq; YP_001000968.1; NC_008787.1.
DR   ProteinModelPortal; Q5QKR8; -.
DR   SMR; Q5QKR8; 1-328.
DR   STRING; 354242.CJJ81176_1310; -.
DR   EnsemblBacteria; EAQ72897; EAQ72897; CJJ81176_1310.
DR   GeneID; 4683631; -.
DR   KEGG; cjj:CJJ81176_1310; -.
DR   PATRIC; 20052597; VBICamJej103413_1308.
DR   eggNOG; COG1086; -.
DR   HOGENOM; HOG000257079; -.
DR   KO; K15894; -.
DR   OMA; ICIHAAA; -.
DR   OrthoDB; EOG6WQD59; -.
DR   BioCyc; CJEJ354242:GC51-1287-MONOMER; -.
DR   Proteomes; UP000000646; Chromosome.
DR   GO; GO:0016829; F:lyase activity; IEA:UniProtKB-KW.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0009058; P:biosynthetic process; IEA:InterPro.
DR   Gene3D; 3.40.50.720; -; 1.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR003869; Polysac_CapD-like.
DR   InterPro; IPR020025; Pseudaminic_synth_PseB.
DR   Pfam; PF02719; Polysacc_synt_2; 1.
DR   TIGRFAMs; TIGR03589; PseB; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Lyase; NADP; Nucleotide-binding.
FT   CHAIN         1    334       UDP-N-acetylglucosamine 4,6-dehydratase
FT                                (inverting).
FT                                /FTId=PRO_0000418956.
FT   NP_BIND      13     16       NADP. {ECO:0000250}.
FT   NP_BIND      37     42       NADP. {ECO:0000250}.
FT   NP_BIND      61     62       NADP. {ECO:0000250}.
FT   NP_BIND     123    124       NADP. {ECO:0000250}.
FT   NP_BIND     168    172       NADP. {ECO:0000250}.
FT   ACT_SITE    127    127       {ECO:0000250}.
FT   BINDING      81     81       NADP; via carbonyl oxygen. {ECO:0000250}.
FT   BINDING      85     85       NADP. {ECO:0000250}.
FT   BINDING      85     85       Substrate. {ECO:0000250}.
FT   BINDING     135    135       NADP. {ECO:0000250}.
FT   BINDING     139    139       NADP. {ECO:0000250}.
FT   BINDING     167    167       Substrate. {ECO:0000250}.
FT   BINDING     175    175       Substrate; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING     193    193       Substrate. {ECO:0000250}.
FT   BINDING     252    252       Substrate. {ECO:0000250}.
FT   BINDING     255    255       Substrate. {ECO:0000250}.
SQ   SEQUENCE   334 AA;  37360 MW;  76899A2106071288 CRC64;
     MFNGKNILIT GGTGSFGKTY TKVLLENYKP NKIIIYSRDE LKQFEMSSIF NSNCMRYFIG
     DVRDKERLSV AMRDVDFVIH AAAMKHVPVA EYNPMECIKT NIHGAQNVID ACFENGVKKC
     IALSTDKACN PVNLYGATKL ASDKLFVAAN NIAGNKQTRF SVTRYGNVVG SRGSVVPFFK
     KLIAQGSKEL PITDTRMTRF WISLEDGVKF VLSNFERMHG GEIFIPKIPS MKITNLAHAL
     APNLSHKIIG IRAGEKLHEI MISSDDSHLT YEFENYYAIS PSIKLVDQES DFSINALGEK
     GQKVKDGFSY SSDNNPQWAS EKELLDIINH TEGF
//
